Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma

Who May Qualify: - Mild to moderate, primary open angle glaucoma - Characteristics consistent with mild to moderate glaucoma - Use of 1 - 4 ocular hypotensive medications at the Screening exam and meets the IOP (intraocular pressure) criteria - Visually significant cataract Who Should NOT Join This Trial: Any of the following prior treatments for glaucoma (study eye): - Laser Trabeculoplasty - Endocyclophotocoagulation (ECP) or Micropulse laser - iStent or iStent Inject - Hydrus Microstent - Trabeculectomy or other bleb forming procedure including Xen, Express, and glaucoma drainage device/valve. - Prior canaloplasty (ab-interno and ab-externo) - Prior goniotomy, or trabeculotomy (ab-interno or ab-externo) - Suprachoroidal stent (e.g., Cypass, iStent Supra, XEN, MINIject) - Concurrent IOP-lowering procedure other than use of the iTrackTM Advance canaloplasty device at the time of surgery (e.g., ECP, CPC, etc.) - Previous treatment with iTrack (Note: permitted if fellow eye only was treated) - Acute angle closure, traumatic, congenital, malignant, uveitic or neovascular glaucoma Always talk to your doctor about whether this trial is right for you.